# Effect of Albendazole Dose on Clearance of Filarial Worms

> **NCT00375583** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 1000 (estimated)

## Conditions studied

- Lymphatic Filariasis
- Wuchereria Bancrofti Infection

## Interventions

- **DRUG:** DEC/Albendazole

## Key facts

- **NCT ID:** NCT00375583
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09-09
- **Primary completion:** 2011-04-28
- **Final completion:** 2011-04-28
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2017-07-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00375583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00375583, "Effect of Albendazole Dose on Clearance of Filarial Worms". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00375583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*